Mirae Asset Global ETFs Holdings
KNSA icon

Mirae Asset Global ETFs Holdings’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,843
Closed -$507K – 3128
2025
Q1 		$507K Buy
22,843
+1,002
+5% +$20.6K ﹤0.01% 1864
2024
Q4 		$432K Buy
21,841
+1,380
+7% +$31.5K ﹤0.01% 1995
2024
Q3 		$511K Buy
20,461
+4,191
+26% +$102K ﹤0.01% 1896
2024
Q2 		$304K Buy
+16,270
New +$305K ﹤0.01% 2064

Other funds holding KNSA

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's KNSA Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2025, closing a stake of 22,843 shares — an estimated $507K sold.

Mirae Asset Global ETFs Holdings first reported a position in KNSA in Q2 2024 and held it in 4 quarters. The position peaked at $511K in Q3 2024. 189 funds tracked by Wall St. Rank hold KNSA as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Kiniksa Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 22,843 Kiniksa Pharmaceuticals shares in Q2 2025, an estimated $507K.
  • Mirae Asset Global ETFs Holdings first reported a position in Kiniksa Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Kiniksa Pharmaceuticals position peaked at $511K in Q3 2024.
  • 189 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.